Lipella Pharmaceuticals Announces Completion of Site
Clinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, ...
Read moreClinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, ...
Read moreBoehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. ...
Read moreNEW YORK, USA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Among the most successful 2023 mobile game launches in Korea; #1 ...
Read moreColoplast, a leading company within intimate healthcare, will invest around 100 million euros in a new manufacturing site in Portugal to ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.